Article
Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation.
Cytokine - 1 Nov 1991
Jacob C O, Hwang F, Lewis G D, Stall A M
Abstract excerpt
Recombinant tumor necrosis factor alpha (TNF-alpha) administration significantly delayed the development of lupuslike nephritis in the New Zealand black x New Zealand white (NZB x NZW)F1 and to a lesser extent in the MRL-lpr/lpr model systems. TNF-alpha treatment was effective when treatment was initiated at 2, 3, or 4 months of age but was ineffective if initiated as late as 6.5 months of age. Treatment of (NZB...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
